| pubmed-article:8475965 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8475965 | lifeskim:mentions | umls-concept:C0025320 | lld:lifeskim |
| pubmed-article:8475965 | lifeskim:mentions | umls-concept:C0282402 | lld:lifeskim |
| pubmed-article:8475965 | lifeskim:mentions | umls-concept:C0014939 | lld:lifeskim |
| pubmed-article:8475965 | lifeskim:mentions | umls-concept:C0033306 | lld:lifeskim |
| pubmed-article:8475965 | lifeskim:mentions | umls-concept:C0178566 | lld:lifeskim |
| pubmed-article:8475965 | lifeskim:mentions | umls-concept:C0443239 | lld:lifeskim |
| pubmed-article:8475965 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:8475965 | pubmed:dateCreated | 1993-5-18 | lld:pubmed |
| pubmed-article:8475965 | pubmed:abstractText | We tested a new hormone replacement formulation based on the hypothesis that interrupted administration of progestin in the presence of continuous estrogen would result in receptor up-regulation and resensitization of target tissues to both estrogen and progestin. As a result, symptom control might be possible with lower doses of steroids and in the absence of withdrawal bleeding. | lld:pubmed |
| pubmed-article:8475965 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8475965 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8475965 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8475965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8475965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8475965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8475965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8475965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8475965 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8475965 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:8475965 | pubmed:issn | 0002-9378 | lld:pubmed |
| pubmed-article:8475965 | pubmed:author | pubmed-author:CasperR FRF | lld:pubmed |
| pubmed-article:8475965 | pubmed:author | pubmed-author:ChapdelaineAA | lld:pubmed |
| pubmed-article:8475965 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8475965 | pubmed:volume | 168 | lld:pubmed |
| pubmed-article:8475965 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8475965 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8475965 | pubmed:pagination | 1188-94; discussion 1194-6 | lld:pubmed |
| pubmed-article:8475965 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:meshHeading | pubmed-meshheading:8475965-... | lld:pubmed |
| pubmed-article:8475965 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8475965 | pubmed:articleTitle | Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy. | lld:pubmed |
| pubmed-article:8475965 | pubmed:affiliation | Department of Obstetrics and Gynecology, University of Toronto, Ontario, Canada. | lld:pubmed |
| pubmed-article:8475965 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8475965 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
